Back to CVE records
Medium 6.5Published Mar 30, 2026

CVE-2026-29597DDSN Interactive cm3 Acora CMS version 10.7.1 contains an improper access control vulnerability.

Updated under an hour ago ()

Does this affect you?

It lists no affected products yet. Add what you run and Signals checks it as products are added.

No exploitation reported and no EPSS estimate yet.

DDSN Interactive cm3 Acora CMS version 10.7.1 contains an improper access control vulnerability. An editor-privileged user can access sensitive configuration files by force browsing the “/Admin/file_manager/file_details.asp” endpoint and manipulating the “file” parameter. By referencing specific files (e.g., cm3.xml), the attacker can retrieve system administrator credentials, SMTP settings, database credentials, and other confidential information. The exposure of this information can lead to full administrative access to the CMS, unauthorized access to email services, compromise of backend databases, lateral movement within the network, and long-term persistence by an attacker. This access control bypass poses a critical risk of account takeover, privilege escalation, and systemic compromise of the affected application and its associated infrastructure.

CVSS
6.5 MEDIUM (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
Weakness (CWE)
CWE-284
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Awaiting Analysis
Record last updated
Jul 5, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

No affected products are listed yet.

References

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.